Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma. (Q52926628)
Jump to navigation
Jump to search
scientific article published in April 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma. |
scientific article published in April 2007 |
Statements
Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma. (English)
Astrid Friebe
Markus J Schwarz
Monika Schmid-Wendtner
Matthias Volkenandt
Folkhart Schmidt
Martin Horn
Gesa Janssen
Martin Schaefer
1 April 2007
30
3
333-337